病理学インフォマティクス市場：製品タイプ、用途、エンドユーザー別-2025-2030年の世界予測

病理学インフォマティクス市場の2023年の市場規模は13億3,000万米ドル、2024年には14億4,000万米ドルに達すると予測され、CAGR 7.98％で成長し、2030年には22億9,000万米ドルに達すると予測されています。

病理学インフォマティクスは、医療ラボにおける診断プロセス、データ管理、臨床解釈を合理化・強化するための情報科学、技術、病理学の交差点に関わる。病理学インフォマティクスの必要性は、大規模なデータセットを統合し、高度な分析ツールを活用することで、臨床検査サービスの効率と精度を向上させる必要性に由来します。そのアプリケーションは、デジタル画像、検査管理システム、電子カルテなど多岐にわたり、病院、診断検査室、研究機関などのエンドユーザーに利益をもたらしています。市場は、自動化された診断ワークフローに対する需要の増加、より効率的な検査室処理を必要とする慢性疾患の負担増、データ分析能力の強化を提供するAIおよび機械学習技術の進歩によって牽引されています。成長を刺激する主な要因としては、デジタル病理技術の継続的な開発やヘルスケアITインフラへの投資の増加が挙げられます。予測診断や個別化医療フレームワークのための人工知能アプリケーションの拡大や、スケーラブルなデータ管理ソリューションのためのクラウドコンピューティングの採用には、潜在的なビジネスチャンスが存在します。

しかし、この市場は、初期設定コストの高さ、データプライバシーに関する懸念、インフォマティクス・システムと既存のラボ・インフラとの統合の複雑さといった制約に直面しています。さらに、データの取り扱いに関連する規制やコンプライアンスに関する潜在的な課題も成長の妨げとなる可能性があります。このような障壁を克服するためには、費用対効果が高くスケーラブルなソリューションの開発や、さまざまな医療ITシステム間の相互運用性の強化に向けた技術革新が必要です。市場競争は激しく、急速に進化しているため、直感的なユーザーインターフェイスの構築やサイバーセキュリティ対策の改善に重点を置いた研究に投資する企業には大きな可能性があります。このようなイノベーションは、病理学インフォマティクスの可能性を最大限に活用し、現在の課題に対処し、この分野におけるビジネスの持続的な成長を確保するために極めて重要です。

市場力学：急速に進化する病理学インフォマティクス市場の主要市場インサイトを公開

病理学インフォマティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の流行と早期診断の重視
  • ヘルスケア活動のデジタル化に向けた政府の取り組み
• 市場抑制要因
  • 病理学インフォマティクスの技術的限界
• 市場機会
  • 病理学インフォマティクスにおけるAI、ML、ビッグデータの統合
  • 病理検査ラボとテクノロジープロバイダーのコラボレーション
• 市場の課題
  • プライバシー侵害に関する懸念

ポーターのファイブフォース：病理学インフォマティクス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：病理学インフォマティクス市場における外部からの影響の把握

外部マクロ環境要因は、病理学インフォマティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析病理学インフォマティクス市場における競合情勢の把握

病理学インフォマティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス病理学インフォマティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、病理学インフォマティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨病理学インフォマティクス市場における成功への道筋を描く

病理学インフォマティクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延と早期診断の重要性
    • ヘルスケア活動のデジタル化に向けた政府の取り組み
  • 抑制要因
    • 病理学インフォマティクスの技術的制限
  • 機会
    • 病理学インフォマティクスにおけるAI、ML、ビッグデータの統合
    • 病理学研究室と技術提供者の連携
  • 課題
    • プライバシー侵害に関する懸念
• 市場セグメンテーション分析
  • タイプ：慢性疾患の増加に対する診断精度の向上を目的としたデジタル病理学システムの普及
  • エンドユーザー：膨大な量のデータを効率的に管理するために診断ラボで広く採用されています
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 病理学インフォマティクス市場：製品タイプ別

• デジタル病理学システム
• 研究室情報管理システム
• 研究室情報システム
• 病理画像ソフトウェア
• ワークフロー管理ソリューション

第7章 病理学インフォマティクス市場：用途別

• がんの診断と治療
• 臨床診断
• 疾病調査
• 医薬品の発見と開発
• テレパソロジー

第8章 病理学インフォマティクス市場：エンドユーザー別

• 診断検査室
• 病院と診療所
• 調査機関および学術センター

第9章 南北アメリカの病理学インフォマティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の病理学インフォマティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの病理学インフォマティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • プロシアのコンセントリク AP-DxがFDA 510（k）承認を取得
  • DedalusとIbex Medical AnalyticsがAI強化診断ソリューションを発表
  • 臨床診断ラボの効率向上のためのPathomationのPIMSのリリース
• 戦略分析と提言

企業一覧

• 3DHISTECH Ltd.
• Abbott Laboratories
• Agilent Technologies, Inc.
• Aiforia Technologies PLC
• Capgemini SE
• Clinisys, Inc.
• Corista LLC
• Danaher Corporation
• F. Hoffmann-La Roche AG
• GE Healthcare
• Huron Digital Pathology
• Illumina, Inc.
• Indica Labs
• Infosys Limited
• International Business Machines Corporation
• Koninklijke Philips N.V.
• Meteor Biotech.
• Olympus Corporation
• OptraSCAN, Inc.
• Paige AI, Inc.
• PathAI
• PerkinElmer Inc.
• Proscia Inc.
• Scitara Corporation
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.
• Xybion Digital Inc.

LIST OF FIGURES

• FIGURE 1. PATHOLOGY INFORMATICS MARKET RESEARCH PROCESS
• FIGURE 2. PATHOLOGY INFORMATICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PATHOLOGY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PATHOLOGY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PATHOLOGY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PATHOLOGY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PATHOLOGY INFORMATICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PATHOLOGY INFORMATICS MARKET DYNAMICS
• TABLE 7. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY DIGITAL PATHOLOGY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY PATHOLOGY IMAGING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY WORKFLOW MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY CANCER DIAGNOSIS & TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY DISEASE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY TELEPATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PATHOLOGY INFORMATICS MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PATHOLOGY INFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CHINA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ITALY PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. POLAND PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. QATAR PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM PATHOLOGY INFORMATICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM PATHOLOGY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM PATHOLOGY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. PATHOLOGY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. PATHOLOGY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

The Pathology Informatics Market was valued at USD 1.33 billion in 2023, expected to reach USD 1.44 billion in 2024, and is projected to grow at a CAGR of 7.98%, to USD 2.29 billion by 2030.

Pathology informatics involves the intersection of information science, technology, and pathology to streamline and enhance diagnostic processes, data management, and clinical interpretation in medical labs. The necessity of pathology informatics stems from the need to improve the efficiency and accuracy of clinical laboratory services by integrating large datasets and utilizing advanced analytic tools. Its applications are vast, encompassing digital imaging, laboratory management systems, and electronic health records, which benefit end-users like hospitals, diagnostic laboratories, and research institutions. The market is driven by the increasing demand for automated diagnostic workflows, the rising burden of chronic diseases necessitating more efficient lab processing, and advancements in AI and machine learning technologies which offer enhanced data analysis capabilities. Key factors stimulating growth include the continuous development of digital pathology technologies and increasing investment in healthcare IT infrastructure. Potential opportunities exist in the expansion of artificial intelligence applications for predictive diagnostics and personalized medicine frameworks, as well as the adoption of cloud computing for scalable data management solutions.

However, the market faces limitations such as high initial setup costs, data privacy concerns, and the complexity of integrating informatics systems with existing lab infrastructure. Additionally, potential regulatory and compliance challenges related to data handling can impede growth. To navigate these barriers, innovations can be directed towards developing cost-effective, scalable solutions and enhancing interoperability among various health IT systems, which would not only overcome integration challenges but also support broader healthcare ecosystem goals. The nature of the pathology informatics market is competitive and rapidly evolving, with significant potential for entities that invest in research focused on creating intuitive user interfaces and improving cybersecurity measures. Such innovations are crucial for harnessing the full potential of pathology informatics, addressing current challenges, and ensuring sustained business growth in the field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pathology Informatics Market

The Pathology Informatics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases and emphasis on early diagnosis
  • Government initiatives for the digitalization of healthcare activities
• Market Restraints
  • Technical limitations of pathology informatics
• Market Opportunities
  • Integration of AI, ML, and big data in pathology informatics
  • Collaboration of pathology labs and technology providers
• Market Challenges
  • Concerns associated with privacy breaches

Porter's Five Forces: A Strategic Tool for Navigating the Pathology Informatics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pathology Informatics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pathology Informatics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pathology Informatics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pathology Informatics Market

A detailed market share analysis in the Pathology Informatics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pathology Informatics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pathology Informatics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pathology Informatics Market

A strategic analysis of the Pathology Informatics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pathology Informatics Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Abbott Laboratories, Agilent Technologies, Inc., Aiforia Technologies PLC, Capgemini SE, Clinisys, Inc., Corista LLC, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Huron Digital Pathology, Illumina, Inc., Indica Labs, Infosys Limited, International Business Machines Corporation, Koninklijke Philips N.V., Meteor Biotech., Olympus Corporation, OptraSCAN, Inc., Paige AI, Inc., PathAI, PerkinElmer Inc., Proscia Inc., Scitara Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., and Xybion Digital Inc..

Market Segmentation & Coverage

This research report categorizes the Pathology Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Digital Pathology Systems, Laboratory Information Management Systems, Laboratory Information Systems, Pathology Imaging Software, and Workflow Management Solutions.
• Based on Application, market is studied across Cancer Diagnosis & Treatment, Clinical Diagnostics, Disease Research, Drug Discovery & Development, and Telepathology.
• Based on End-User, market is studied across Diagnostic Laboratories, Hospitals and Clinics, and Research Institutes & Academic Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and emphasis on early diagnosis
    • 5.1.1.2. Government initiatives for the digitalization of healthcare activities
  • 5.1.2. Restraints
    • 5.1.2.1. Technical limitations of pathology informatics
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of AI, ML, and big data in pathology informatics
    • 5.1.3.2. Collaboration of pathology labs and technology providers
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with privacy breaches
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Proliferation of digital pathology systems for enhanced diagnostic accuracy against rising chronic diseases
  • 5.2.2. End-User: High adoption in diagnostic laboratories to manage a vast amount of data efficiently
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pathology Informatics Market, by Product Type

• 6.1. Introduction
• 6.2. Digital Pathology Systems
• 6.3. Laboratory Information Management Systems
• 6.4. Laboratory Information Systems
• 6.5. Pathology Imaging Software
• 6.6. Workflow Management Solutions

7. Pathology Informatics Market, by Application

• 7.1. Introduction
• 7.2. Cancer Diagnosis & Treatment
• 7.3. Clinical Diagnostics
• 7.4. Disease Research
• 7.5. Drug Discovery & Development
• 7.6. Telepathology

8. Pathology Informatics Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Hospitals and Clinics
• 8.4. Research Institutes & Academic Centers

9. Americas Pathology Informatics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pathology Informatics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pathology Informatics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Proscia's Concentriq AP-Dx Secures FDA 510(k) Clearance
  • 12.3.2. Dedalus and Ibex Medical Analytics Unveil an AI-Enhanced Diagnostic Solution
  • 12.3.3. The Launch of Pathomation's PIMS for Enhanced Clinical Diagnostic Lab Efficiencies
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3DHISTECH Ltd.
• 2. Abbott Laboratories
• 3. Agilent Technologies, Inc.
• 4. Aiforia Technologies PLC
• 5. Capgemini SE
• 6. Clinisys, Inc.
• 7. Corista LLC
• 8. Danaher Corporation
• 9. F. Hoffmann-La Roche AG
• 10. GE Healthcare
• 11. Huron Digital Pathology
• 12. Illumina, Inc.
• 13. Indica Labs
• 14. Infosys Limited
• 15. International Business Machines Corporation
• 16. Koninklijke Philips N.V.
• 17. Meteor Biotech.
• 18. Olympus Corporation
• 19. OptraSCAN, Inc.
• 20. Paige AI, Inc.
• 21. PathAI
• 22. PerkinElmer Inc.
• 23. Proscia Inc.
• 24. Scitara Corporation
• 25. Siemens Healthineers
• 26. Thermo Fisher Scientific, Inc.
• 27. Xybion Digital Inc.